VAERS reports by lot

Merck Pneumococcal lot S026366: VAERS reports

61 VAERS reports list lot S026366 as a Merck Pneumococcal vaccine, received between 2019-10-31 and 2020-10-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
61
Reports
5%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4625%
Cardiac / Cardiovascular3720%
General / Systemic (non-local)2413%
Allergic / Anaphylactic2312%
Musculoskeletal1910%
Dermatological (non-injection-site)147%
Neurological126%
Respiratory42%
Gastrointestinal42%
Thrombotic / Hematological32%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania9
Texas6
Florida5
Ohio3
Tennessee3
Nebraska3
California2
South Carolina2
Oregon2
Indiana2
Michigan2
Illinois2

Reports by month received

2019-103
2019-1116
2019-1213
2020-017
2020-024
2020-031
2020-043
2020-073
2020-081
2020-091
2020-109

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.